Sakai, A.; Iijima, H.; Ebisumoto, K.; Yamauchi, M.; Teramura, T.; Yamazaki, A.; Watanabe, T.; Inagi, T.; Maki, D.; Okami, K.
Prognostic Value of Inflammatory and Nutritional Biomarkers of Immune Checkpoint Inhibitor Treatment for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. Cancers 2023, 15, 2021.
https://doi.org/10.3390/cancers15072021
AMA Style
Sakai A, Iijima H, Ebisumoto K, Yamauchi M, Teramura T, Yamazaki A, Watanabe T, Inagi T, Maki D, Okami K.
Prognostic Value of Inflammatory and Nutritional Biomarkers of Immune Checkpoint Inhibitor Treatment for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. Cancers. 2023; 15(7):2021.
https://doi.org/10.3390/cancers15072021
Chicago/Turabian Style
Sakai, Akihiro, Hiroaki Iijima, Koji Ebisumoto, Mayu Yamauchi, Takanobu Teramura, Aritomo Yamazaki, Takane Watanabe, Toshihide Inagi, Daisuke Maki, and Kenji Okami.
2023. "Prognostic Value of Inflammatory and Nutritional Biomarkers of Immune Checkpoint Inhibitor Treatment for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck" Cancers 15, no. 7: 2021.
https://doi.org/10.3390/cancers15072021
APA Style
Sakai, A., Iijima, H., Ebisumoto, K., Yamauchi, M., Teramura, T., Yamazaki, A., Watanabe, T., Inagi, T., Maki, D., & Okami, K.
(2023). Prognostic Value of Inflammatory and Nutritional Biomarkers of Immune Checkpoint Inhibitor Treatment for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. Cancers, 15(7), 2021.
https://doi.org/10.3390/cancers15072021
